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Background: Caffeine is an active alkaloid that can cause damage to bones in formation during prenatal life into
adulthood. This compound can pass across the placenta and into the mother’s milk, causing a reduction in bone
formation, growth and mass. The objective of this study was to examine the osteogenic potential of osteoblasts
extracted from neonatal rats born to mothers treated with caffeine throughout pregnancy.
Methods: Twenty-four adult Wistar rats were randomly divided into four groups, consisting of one control group
and three groups that were treated with 25, 50, or 100 mg/kg of caffeine by an oral-gastric probe throughout the
duration of the experimental period (pregnancy). At birth, three puppies from each dam in each group were euthanized,
and osteoblasts were extracted from the calvaria of these pups for in vitro testing.
Results: The osteoblasts extracted from the pups of rats that received 50 mg/kg caffeine during pregnancy exhibited
increased expression of osteocalcin, osteopontin, sialoprotein, runx-2, alkaline phosphatase and type I collagen transcripts,
resulting in increased synthesis of mineralization nodules.
Conclusions: Neonates from rats treated with 50 mg/kg caffeine during pregnancy contained osteoblasts with a higher
osteogenic potential characterized by increased expression of osteocalcin, osteopontin, sialoprotein, runx-2, alkaline
phosphatase and type I collagen and increased synthesis of mineralization nodules.
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Caffeine is a pharmacologically active xanthine (1,3,7-tri-
methylxanthine) that is present in coffees, teas, soft
drinks, food, and drugs [1].
Despite the beneficial effects of caffeine on the central
nervous system and the respiratory system, characterized
by reduced fatigue and bronchodilation, respectively, the
adverse effects of caffeine on the body are more widely
documented. Caffeine is known to cause insomnia and
anxiety as well as increased blood pressure and pulse. In
addition, caffeine is considered a risk factor for osteo-
porosis and periodontal disease and a causative agent of* Correspondence: serakidesufmg@gmail.com
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unless otherwise stated.fetal malformations, reductions in body weight, reduced
length of long bones and reduced length of vertebrae in
newborns [1-7].
Caffeine crosses the placenta leading to substantial
amounts in amniotic fluid, umbilical cord blood, new-
born plasma and newborn urine and is also carried by
the mother’s milk in both mice and humans [8-11].
Pregnant women in the third trimester of pregnancy
with low caffeine consumption had mean serum levels
of caffeine in their umbilical cord blood of 0.48 μg/ml
(0 to 10.49 μg/ml). Pregnant women with caffeine intake
greater than 300 mg/day averaged 2.1 μg/ml of caffeine in
their cord blood [9]. Even in humans, maternal ingestion
of 36–335 mg of caffeine has been shown to be transmit-
ted in the milk, which contained between 2.09 to
7.17 μg/ml caffeine [11]. Previous studies have shown
that caffeine causes changes in the bones of fetusesis is an Open Access article distributed under the terms of the Creative
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iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Reis et al. BMC Musculoskeletal Disorders  (2015) 16:10 Page 2 of 11and young rats. In rat fetuses born to mothers treated
with high doses of caffeine, teratogenic changes such
as cleft palate, limb malformations, and ectrodactyly
[12-14] have been observed, as well as reduced bone
mass [15] and reduced bone mineral content [4]. In
the offspring of rats treated with caffeine at doses of
25, 50 and 100 mg/kg, osteopenia in the long bones
and vertebrae was observed [15]. High doses of caffeine
inhibit the endochondral bone growth of offspring when
administered to rats during pregnancy and lactation. The
effects of caffeine are more damaging to cartilage growth
in newborns than to pups at weaning [15]. In humans,
caffeine intake above 540 mg/day during pregnancy is
associated with decreased weight and fetal growth, and
combining caffeine intake with smoking and alcohol con-
sumption may further increase risk [16,17].
The mechanism that underlies the changes caused by
caffeine, especially in the bones, requires further study.
The effects of caffeine on bone metabolism are contro-
versial. Some studies suggest that the consumption of
caffeine has been associated with low bone mass and in-
creased fracture risk and that caffeine directly enhances
differentiation and maturation of osteoclasts [18,19].
Additionally, it has been postulated that one mechanism
by which caffeine alters bone formation and growth is by
affecting mesenchymal stem cells and osteoblasts [20,21].
In vitro studies have concluded that caffeine can potentially
harm osteoblasts, causing a reduction in viability and syn-
thetic activity [20-23]. The dosage of caffeine can influence
the osteogenic differentiation of mesenchymal stem cells
[24]. Low doses of caffeine (0.1 mM) in culture medium
can increase the mineralization, alkaline phosphatase activ-
ity and differentiation genes such as osteocalcin, osteopro-
tegerin, and Runx-2, whereas higher doses (≥0.3 mM) can
suppress differentiation [24]. However, little is known
about the effects, associated factors and molecular mecha-
nisms of caffeine action during skeletogenesis. Most previ-
ous studies that have addressed this issue have investigated
the effects of adding caffeine to cultured mesenchymal
stem cells and osteoblasts [20-23]. This, however, is the
first study to examine the osteogenic potential of osteo-
blasts extracted from neonatal rats born to mothers treated
with caffeine throughout pregnancy.
The osteogenic potential of the cells was evaluated using
parameters such as alkaline phosphatase activity; collagen
synthesis; gene expression of Runx-2, collagenous proteins
and non-collagenous proteins (osteocalcin, osteopontin,
sialoprotein); and the synthesis and mineralization of the
extracellular matrix. Runx-2 regulates collagenous and
non-collagenous protein factors that play a key role in the
various stages of differentiation in the extracellular matrix
[25-29], while alkaline phosphatase is an early marker of
osteogenic differentiation [30,31]; these factors are thus
important to evaluate.Therefore, with the aim of elucidating the mechanism of
action of caffeine in osteoblasts, this study analyzed the ef-
fects of caffeine on the synthetic activity of cells extracted
from the calvaria of newborn rats whose mothers received
different doses of caffeine during pregnancy.
Methods
Animals and study design
Twenty-four two-month-old female Wistar rats were
used in this study. The animals were housed six per cage
by experimental group in a 12-h light/dark cycle. They
were fed commercial rat chow containing 22% crude pro-
tein, 1.4% calcium and 0.6% phosphorus. Food and water
were provided ad libitum to all animals. All experimental
procedures were approved by the Institutional Ethics Com-
mittee in Animal Experimentation at Universidade Federal
de Minas Gerais (UFMG) (protocol no. 177/2010).
After a 30-day adaptation period, the rats were ran-
domly divided into four groups, consisting of three
groups that were treated with different doses of caffeine
and a control group. The treated groups (6 animals/
group) received daily caffeine (Sigma Aldrich, St. Louis,
MO, USA) diluted in 5 mL of distilled water at doses of
25, 50 or 100 mg/Kg. The doses of caffeine used in this
study were chosen based on previously observed effects
on endochondral ossification in the offspring of rats
treated with caffeine [15].
The doses were administered by an oral-gastric probe at
the same time each day over the course of the experimen-
tal period. As a placebo, the control group received 5 mL
of distilled water daily by an oral-gastric probe. The fe-
males were subjected to vaginal cytology to monitor the
estrous cycle [32]. The female rats that were in estrus and
proestrus were kept in plastic cages with adult male rats
for 12 h. After this period, vaginal smears were obtained
daily to detect spermatozoa. Copulation was confirmed by
the presence of spermatozoa in the vaginal cytology sam-
ples, and the day of copulation was considered Day 0 of
gestation. After copulation, the females were kept indi-
vidually in plastic cages. The animals in the treated and
control groups continued to receive caffeine or water,
respectively, by an oral-gastric probe throughout the
duration of the experimental period (pregnancy).
At birth, three pups from each dam in each experimen-
tal group were euthanized, and osteoblasts were extracted
from the calvaria of these pups. The cells were pooled to
obtain a cell suspension for in vitro tests. The means and
standard deviations were determined from six replicates
for each experimental group.
Harvest and culture of osteoblasts from calvaria of
newborn pups
Calvarial osteoblast cultures were established as described
previously [26,33]. Briefly, 2 day-old neonatal Wistar rats
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off and immersed in phosphate-buffered saline (PBS)
(Synth, São Paulo, SP, Brazil). The calvaria were then dis-
sected out and processed for cell isolation and culture. The
calvaria were fragmented and incubated for 15 min with
1% trypsin (Gibco, Grand Island, NY, USA) and then for
60 min at 37°C in PBS with 0.25% collagenase (Type I;
Sigma, St Louis, MO, USA). The cells that dissociated from
the fragments of calvaria were washed several times in
PBS, suspended in DMEM medium (Gibco, Grand Island,
NY, USA) supplemented with 10% fetal bovine serum
(Gibco, Grand Island, NY, USA) and antibiotics (60 μg/L
gentamicin, 25 μg/L amphotericin B, 100 U/mL penicillin
and 100 μg/mL streptomycin; Gibco, Grand Island, NY,
USA), and collected in a 75-cm2 culture flask containing
10 mL of culture medium. The cells were grown at 37°C in
a 5% CO2 atmosphere for 3 days. The non-adherent cell
population was removed, and the adherent layer was
washed once with fresh medium. The culture medium was
changed twice a week during culturing.
Culture of osteoblasts in osteogenic differentiation medium
After the fourth passage, the adherent cells were harvested
by treatment with trypsin. They were then counted and
plated in 6- and 24-well culture plates (1 × 104 cells/cm2).
The cells were cultured in osteogenic medium, which con-
sists of DMEM (Gibco, Grand Island, NY, USA) supple-
mented with 10% fetal bovine serum (Gibco, Grand
Island, NY, USA), antibiotics (60 μg/L gentamicin, 25 μg/L
amphotericin B, 100 U/mL penicillin, 100 μg/mL strepto-
mycin; Gibco, Grand Island, NY, USA), 10 mM β-glycero-
phosphate (Sigma, St. Louis, MO, USA), 50 μg/mL
ascorbic acid (Merck, Germany) and 10 nM dexametha-
sone (Sigma-Aldrich, St Louis, MO, USA) [26,33]. The
cells were grown at 37°C in a 5% CO2 atmosphere. The
cells were grown for 7, 14 and 21 days to assess the con-
version of MTT into formazan crystals, collagen synthesis,
alkaline phosphatase activity, production of mineralized
nodules and the expression of osteocalcin, osteopontin,
bone sialoprotein, alkaline phosphatase and type I collagen
via qRT-PCR.
MTT reduction assay
MTT conversion is a measure of cell viability. Briefly,
the cells were incubated with MTT (3-(4,5-dimethyl-
thiazol-2-yl)-2,5 diphenyltetrazolium bromide) (Invitro-
gen, Eugene, Oregon, USA) for 2 h at 37°C. After
incubation with MTT, the cells were treated for 12 h
with a solubilization solution (sodium dodecyl sulfate in
10% HCl) (Synth, São Paulo, SP, Brazil), and the absorb-
ance of the solubilized MTT formazan product was mea-
sured at 595 nm using a microtiter plate reader [23,24].
The means and standard deviations were determined
from six replicates for each experimental group.Alkaline phosphatase activity
At the end of each period (7, 14 and 21 days), the osteo-
blasts from the newborn pups of all groups were cul-
tured in 24-well plates and washed with 0.15 M PBS.
Two hundred microliters of BCIP/NBT solution (1 mL
of alkaline phosphatase buffer, 4.4 μL of NBT {nitro-blue
tetrazolium chloride} and 3.3 μL of BCIP {5-bromo-4-
chloro-3’-indolylphosphate p-toluidine salt}) (Invitrogen,
Camarilho, CA, USA) were added to each well. The plates
were incubated for 2 h at 37°C. After incubation with
BCIP/NBT, the cells were treated with a solubilization so-
lution (sodium dodecyl sulfate in 10% HCl) (Synth, São
Paulo, SP, Brazil), and the absorbance of the solubilized
BCIP/NBT was measured at 595 nm using a microtiter
plate reader [34,35]. The means and standard deviations
were determined from six replicates for each experimental
group.
Collagen synthesis
At the end of each period (7, 14 and 21 days), the osteo-
blasts of newborn pups of all groups were cultured in
6-well plates and washed with 0.15 M PBS (Synth, São
Paulo, SP, Brazil). Four milliliters of Bouin solution (Merk,
Germany) was added to each well. The samples were incu-
bated for 2 h at 37°C and subsequently moved to a re-
frigerator. The following day, the cells were washed, dried
and incubated in Sirius Red (Reagent, Rio de Janeiro, RJ,
Brazil) (2 mL) for 30 min. After the dye was removed, the
cells were washed with HCl (Synth, São Paulo, SP, Brazil)
and NaOH (Synth, São Paulo, SP, Brazil) and incubated
for 30 min. Subsequently, 100 μL from each well was
transferred to a 96-well plate, and the absorbance of each
sample at 540 nm was analyzed using a plate reader [33].
The means and standard deviations were determined from
six replicates for each experimental group.
Mineralization assay
The cells were cultured in six-well culture plates with 22 ×
22 mm coverslips. The cells were washed in PBS (Synth,
São Paulo, SP, Brazil), fixed in 4% paraformaldehyde (Synth,
São Paulo, SP, Brazil) and rinsed with deionized water. After
the addition of a 5% silver nitrate solution (Synth, São
Paulo, SP, Brazil), the wells were exposed to light for 2 h.
The plates were rinsed with deionized water, and the re-
sidual silver nitrate was neutralized by 5% sodium thiosul-
fate (Synth, São Paulo, SP, Brazil); after neutralization, the
calcium deposits were visible by dark brown staining. The
percentage of mineralized nodules was assessed by light
microscopy. The mean percentage of nodules was quanti-
fied at 21 days of osteogenic differentiation; 50 fields were
counted using a 10× objective and a 121-point graticule
superimposed on the histological sections [36]. The means
and standard deviations were determined from six rep-
licates for each experimental group.
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Total mRNA was extracted using TRIzol reagent (Ambion,
Carlsbad, CA, USA) according to the manufacturer’s in-
structions. Osteoblasts from each experimental group
cultured in osteogenic medium for 7, 14, or 21 days were
assayed for osteocalcin, osteopontin, bone sialoprotein,
alkaline phosphatase and type I collagen expression. Osteo-
blasts cultured in osteogenic medium for 21 days were
assayed for runx-2 expression. The means and standard
deviations were determined from four replicates for each
experimental group. One microgram of RNA was sub-
jected to cDNA synthesis using a SuperScript III Plat-
inum Two-Step qPCR kit with SYBR Green (Invitrogen,
Carlsbad, CA, USA). The qRT-PCR reactions were con-
ducted in a Smart Cycler II thermocycler (Cepheid,
Carpinteria, CA, USA). The one-step qRT-PCR amplifi-
cation started with reverse transcription for 120 s at
50°C, followed by PCR with the following parameters:
45 cycles of 15 s at 95°C and 30 s at 60°C. At the end of
each run, the fluorescence data were analyzed to obtain
CT values. Gene expression was calculated using the
2-ΔΔCt method, where the values from samples were
averaged and normalized to GAPDH CT values. The
specific primers used are shown in Table 1. The results
for each group were compared quantitatively after
normalization to the expression of Rattus norvegicus
GAPDH.Statistical analysis
The means and standard deviations were determined for
each variable. We performed ANOVA and compared theTable 1 List of genes and oligonucleotide sequences of
the primers used for real-time RT-PCR
Gene Primers: 5′-3′ Access
number




Foward: ACGTCCTGGTGAAGTTGGTC NM 000088
Reverse: CAGGGAAGCCTCTTTCTCCT




Foward: TGTCCTTCTGAACGGGTTTC NM 012587.2
Reverse: CTTCCCCATACTCAACCGTG






Runx-2 Forward: GCGTCAACACCATCATTCTG NM_004348
Reverse: CAGACCAGCAGCACTCCATCmeans using an SNK test. Differences were considered
to be significant at p < 0.05 [37].Results
Conversion of MTT to formazan crystals
The conversion of MTT into formazan crystals varied
with the dose of caffeine administered to the mother
and the culture period. At 7 days, the groups treated
with 25 and 50 mg/kg caffeine showed less conversion
of MTT into formazan crystals than the control group.
However, at 14 days, osteoblasts from all the caffeine-
treated groups (25, 50 and 100 mg/kg) showed decreased
conversion of MTT into formazan crystals compared
with the controls (p ≤ 0.05). At 21 days, the groups
treated with 25 and 50 mg/kg caffeine showed no dif-
ference in the conversion of MTT to formazan crystals
relative to the control group; however, the 100 mg/kg
group showed a significant increase compared with the
control group (Figure 1).Alkaline phosphatase activity and synthesis of collagen
At 7 days of culture, the groups treated with 50 and
100 mg/kg caffeine showed significantly higher alkaline
phosphatase activity than the controls. At 14 days, the
osteoblasts isolated from the 25 and 50 mg/kg groups
showed significantly higher alkaline phosphatase activity
than the control group. At 21 days of culture, only the
group treated with 50 mg/kg caffeine maintained signifi-
cantly higher alkaline phosphatase activity over than of
the control group (Figure 2a).
At 7 days of culture, the groups treated with 50 and
100 mg/kg caffeine showed significantly higher collagen
synthesis than the control group. At 14 days of culture,
all three caffeine-treated groups showed significantly
higher collagen synthesis than the controls. However, at
21 days of culture, only the osteoblasts cultured from
the 50 mg/kg group maintained this increased collagen
synthesis (p ≤ 0.05) (Figure 2b).Synthesis of mineralization nodules
At 7 and 14 days of culture, there was variation among
the cultures in the percentages of mineralization nod-
ules, but there were no significant differences between
the groups. However, at 21 days, the amount of variation
was reduced, as indicated by a decrease in the standard
deviations. The osteoblast cultures from the 50 mg/kg
caffeine-treated group showed a significant increase in
the percentage of mineralization nodules compared with
the control group (Figure 3a). Furthermore, the calcium
content of the nodules, as reflected by black staining,
was higher in the group treated with 50 mg/kg caffeine
than in the other groups (Figure 3b).
Figure 1 Cell viability (mean ± standard deviation) characterized by conversion of MTT into formazan crystals by calvarial osteoblasts
taken from newborn control rats or those exposed to various concentrations of caffeine (25, 50, 100 mg/Kg) during pregnancy and
subsequently cultured in osteogenic differentiation medium for 7, 14 or 21 days. *p <0.05, **p < 0.01, ***p < 0.001.
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At 7 days, the group treated with 25 mg/kg caffeine showed
a significant increase in osteocalcin expression, while the
100 mg/kg group showed a significant reduction in the ex-
pression of this gene. However, at 14 and 21 days of culture,
the osteoblasts of the 50 mg/kg caffeine-treated group
showed a significant increase in the expression of osteocal-
cin compared with the control group (Figure 4a). Osteo-
pontin expression was significant higher in all of the
caffeine-treated groups (25, 50 and 100 mg/kg) at 7 days of
culture than in the control group. However, at 14 and
21 days of culture, only the osteoblasts from the 25 andFigure 2 Alkaline phosphatase activity (a) and synthesis of collagen (
newborn control rats or those exposed to various concentrations of c
cultured in osteogenic differentiation medium for 7, 14 or 21 days. *p50 mg/kg groups showed significantly higher expression of
osteopontin (Figure 4b). At 7 days, sialoprotein expression
was significantly increased in the 25 mg/kg group, but
significantly decreased in the 100 mg/kg group. At 14 days,
osteoblasts from the groups treated with 25 and 50 mg/kg
caffeine showed significantly higher expression of sialopro-
tein than the control group. However, at 21 days, only oste-
oblasts from the group treated with 50 mg/kg caffeine
maintained significantly higher sialoprotein expression than
the controls (Figure 5a).
At 21 days of culture, only the group treated with
50 mg/kg caffeine showed a significant increase in runx-2b) (mean ± standard deviation) in calvarial osteoblasts taken from
affeine (25, 50, 100 mg/Kg) during pregnancy and subsequently
< 0.05, **p < 0.01, ***p < 0.001.
Figure 3 Percentage of mineralization nodules/field (mean ± standard deviation) (a) and Von Kossa staining (b) of calvarial osteoblasts
taken from newborn control rats and those exposed to various concentrations of caffeine (25, 50, 100 mg/Kg) during pregnancy and
subsequently cultured in osteogenic differentiation medium for 21 days. ***p < 0.001. Bar = 58.5 μm.
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all other experimental periods and doses exhibited no
significant differences in runx-2 expression compared
with the control group.
At 7 and 14 days of culture, alkaline phosphatase expres-
sion was significantly increased compared with controls
only in the group treated with 50 mg/kg caffeine. At
21 days, there were no differences in alkaline phosphatase
expression between the groups (Figure 6a). At 7 and
14 days, the group treated with 25 mg/kg caffeine had
lower type I collagen expression than the controls, and
the group treated with 50 mg/kg caffeine had higher
expression. At 21 days of culture, there were no signifi-
cant differences in type I collagen expression between
the groups (Figure 6b).
Discussion
Previous studies with cultured osteoblasts showed that
caffeine can be harmful [20-23] and may be considered a
risk factor for osteoporosis [18,29] and a causative agentof fetal malformations [5,12,14,15]. The mechanisms that
underlie these changes in bone tissue remain poorly
understood [5,12,15,38-40]. To the best of our know-
ledge, this work describes for the first time the effects of
caffeine administration during pregnancy on the osteo-
genic potential of osteoblasts derived from pups.
The majority of cells extracted from calvaria are osteo-
blasts, although the derived cell population also includes
pre-osteoblasts [41]. In the present study, these cells
were evaluated after passaging three times in osteogenic
medium to stimulate the differentiation of all extracted
cells. To characterize and compare the osteogenic poten-
tial of the osteoblasts extracted from each experimental
group, several parameters were evaluated: alkaline phos-
phatase activity, collagen synthesis, and the synthesis and
mineralization of the extracellular matrix. During the
process of cell differentiation, osteoblasts produce the
bone extracellular matrix, which is composed of collage-
nous and non-collagenous proteins. Many of these pro-
teins play a key role in the various stages of differentiation
Figure 4 The relative quantification (mean ± standard deviation) of osteocalcin (a) and osteopontin (b) transcripts as measured by
real-time RT-PCR in calvarial osteoblasts taken from newborn control rats and those exposed to various concentrations of caffeine during
pregnancy and subsequently cultured in osteogenic differentiation medium for 7, 14 or 21 days. *p <0.05, **p < 0.01, ***p < 0.001.
Figure 5 The relative quantification (mean ± standard deviation) of sialoprotein (a) and runx-2 (b) transcripts as measured by real-time
RT-PCR in calvarial osteoblasts taken from newborn control rats and those exposed to various concentrations of caffeine (25, 50, 100 mg/Kg)
during pregnancy and subsequently cultured in osteogenic differentiation medium for 7, 14 or 21 days. *p <0.05, **p < 0.01, ***p < 0.001.
Reis et al. BMC Musculoskeletal Disorders  (2015) 16:10 Page 7 of 11
Figure 6 The relative quantification (mean ± standard deviation) of alkaline phosphatase (a) and type I collagen transcripts (b) as
measured by real-time RT-PCR in calvarial osteoblasts from newborn control rats and those exposed to various concentrations of
caffeine (25, 50, 100 mg/Kg) during pregnancy and subsequently cultured in osteogenic differentiation medium for 7, 14 or 21 days.
*p <0.05, **p < 0.01, ***p < 0.001.
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osteocalcin, sialoprotein and osteopontin [20,41,42], which
were evaluated in this study.
Our results were surprising and interesting. In contrast
with previously reported results from in vitro studies
[20,21], we found that caffeine, predominantly at 50 mg/
kg, increased the osteogenic potential of osteoblasts, as
characterized by increased alkaline phosphatase activity,
collagen synthesis, mineralization of nodules and expres-
sion of osteogenic genes including osteocalcin, osteo-
pontin, Runx-2, sialoprotein, alkaline phosphatase and
type I collagen.
The methodology used and the results obtained in this
study were different from those reported by other re-
searchers; previous studies showed that the viability and
activity of osteoblasts decreased significantly when ex-
posed to increasing doses of caffeine (0.4, 0, 5, 1.0 and
10 mM) in the culture medium [20-23]. The most im-
portant aspect of our method of caffeine administration
is that the drug was not added to the culture medium as
in most of the previous studies; we administered caffeine
to mothers during pregnancy, and the drug passed
through the placenta to the fetus. The doses of caffeine
used in this study were chosen based on previously ob-
served effects on endochondral ossification in the off-
spring of rats treated with caffeine [15]. When added
directly to the culture medium, caffeine inactivates cellsurvival signaling and promotes programmed cell death
by a mitochondria-dependent cascade; cell death thus
occurs by apoptosis and necrosis [20-23]. Furthermore,
there is decreased expression of genes, enzymes and pro-
teins expressed during osteogenesis, such as Runx-2, alka-
line phosphatase, type I collagen, osteocalcin, osteopontin,
and histones [21-23,43]. The results obtained with the
addition of caffeine to osteoblast cultures demonstrate
that in addition to reducing cell viability, caffeine also
inhibits the synthesis of the extracellular matrix [22,23].
However, in vitro assays may be different from in vivo
and ex vivo assays because the cellular microenviron-
ment of the organism is difficult to reproduce in vitro
due to numerous interdependent intrinsic and extrinsic
factors. The control of proliferation, differentiation and
cell maintenance is carried out by genes, cytokines, de-
velopmental and growth factors and cellular interactions
[44-46]. Thus, even with our knowledge of the regula-
tion of the cellular microenvironment, it is difficult to
develop in vitro models that can simulate drug effects in
the body [44-46]. Although in vitro assays with cultured
osteoblasts reproduce the cellular sequences that occur
before and during the formation of bone matrix in vivo
[41], the drugs used in in vitro studies are added directly
to the culture medium and not metabolized by the body.
This lack of drug metabolism may potentiate the effects
of drugs on cells [21,43]. The aim of this study was to
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blasts in pups whose mothers were exposed to caffeine
during pregnancy, taking into consideration the metabo-
lism of the drug by the mother and its passage to the fetus
through the placenta.
At 7 and 14 days, alkaline phosphatase activity and
collagen synthesis were significantly higher in the group
that received 50 mg/kg caffeine than in controls, based
on both colorimetric assays and RT-PCR. Alkaline phos-
phatase is an early marker of osteogenic differentiation
[47,48]; therefore, the increase in alkaline phosphatase sug-
gests an increase in differentiation and early osteogenesis
in the treated group compared with the control group.
However, the increase in the gene transcript does not ne-
cessarily mean that the protein was also increased. In tests
of the conversion of MTT into formazan crystals, osteo-
blasts from rat neonates that received a dose of 50 mg/kg
caffeine showed a lower conversion of MTT into formazan
at 7 and 14 days of culture. We cannot infer that these re-
sults are due to a reduction in cell viability. We postulate
that this observation may be due to an increase in differen-
tiation, as evidenced by collagen synthesis, MTT, and the
synthesis of non-collagenous proteins and mineralization
nodules, which are discussed below. The MTT assay is a
cell viability test; the formation of formazan crystals de-
pends on the mitochondrial activity of viable cells. How-
ever, mitochondrial activity also varies with cell maturity,
and the decrease in mitochondrial activity during matur-
ation means that differentiated cells frequently show a re-
duction in formazan crystal formation [49,50]. At caffeine
doses of 25 mg/kg and 50 mg/kg, the osteoblasts showed
decreased conversion of MTT into formazan crystals after
7 and 14 days of culture. At 21 days, the group treated
with 100 mg/kg caffeine showed higher conversion of
MTT into formazan crystals than the controls. Except
for the 50 mg/kg group, it is difficult to explain the
changes observed in the MTT assays of the groups that
were treated with caffeine. Because the MTT assay is
dependent on mitochondrial activity, more studies should
be conducted to study the effects of caffeine on these cellu-
lar organelles.
Of the three doses of caffeine studied, the 50 mg/kg dose
resulted in elevated type I collagen and alkaline phosphatase
expression, enhanced synthesis and mineralization of nod-
ules and increased expression of non-collagenous proteins
such as osteocalcin, collagen, sialoprotein, Runx-2 and
osteopontin compared with the control group at the stud-
ied time points. These proteins are important indicators
of late osteogenic differentiation [41,51-57]. Therefore, it
can be inferred that the osteoblasts cultured from the off-
spring of rats treated with caffeine at a dose of 50 mg/kg
showed increased osteogenic potential in the early and late
stages of differentiation. The increased osteogenic poten-
tial of osteoblasts in this study should be interpreted withcaution, and further studies are needed to understand the
relationship between these results and the bone changes
observed in vivo. This increase should not necessarily
be interpreted as beneficial for bone growth because any im-
balance in cellular function, whether an increase or decrease,
may impair skeletogenesis. Caffeine binds to adenosine
receptors, and modulate several others receptors including
glucocorticoid receptors, insulin, estrogen, androgen, vitamin
D, cannabinoid, glutamate and adrenergic receptors, all
of which are expressed in osteoblasts or osteoprogenitor
cells and have important functions during osteoblast differen-
tiation [23,58-72]. However, little is known about the
action of caffeine on these receptors or the resultant effects
on endochondral bone formation and growth. Therefore,
unfortunately, it is too early to determine the implications for
humans or to suggest a mechanism of action for the observed
increase in osteogenic factors. Numerous factors in the
cellular microenvironment could also be responsible for the
observed effects, although more studies are needed to identify
these factors and elucidate their mechanisms of action.
Although 25 mg/kg of caffeine also increased the expres-
sion of osteocalcin, sialoprotein and osteopontin at two of
the time points studied, the synthesis of mineralization
nodules was not affected at this dose. This result is
likely due to the reduction of collagen expression observed
in this group. The formation of mineralization nodules
depends on the synthesis of non-collagenous proteins and
collagen prior to the mineralization process [41]. A dose of
100 mg/kg caffeine also promoted changes in the transcript
levels of osteocalcin, osteopontin and sialoprotein at 7 days
but did not alter the synthesis of mineralization nodules
compared with the controls. However, it is important to
note that with the exception of the MTT assay at 21 days,
the 25 mg/kg and 100 mg/kg doses were similar to the
controls in all parameters evaluated.
Conclusions
In conclusion, osteoblasts extracted from the pups of rats
that received caffeine at a dose of 50 mg/kg during preg-
nancy exhibit increased expression of osteocalcin, osteo-
pontin, sialoprotein, runx-2, alkaline phosphatase, and type
I collagen, resulting in increased synthesis of mineralization
nodules. Our work presents novel results using method-
ology not previously performed and demonstrates the need
for further studies to better understand the significance of
our results and the differences in effects on osteogenic
potential when caffeine is administered in vivo or directly
to culture media.
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